Follow the people · Insider
Lars Holtug
Lars Holtug files insider transactions with the SEC as a director of Ascendis Pharma A/S (ASND). We hold 1 disclosed purchase or sale filed since 3 September 2026, 1 of them in the last 90 days.
- Files forASND
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 September 2026 — 2 September 2026Director · Ascendis Pharma A/S (ASND)1 Form 4 line · source: SEC Form 4
Everything they disclosed
1 entry, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 236 shares of Ascendis Pharma A/SSEC Form 43 September 2026Ordinary Shares · traded 2 September 2026 · filed 3 September 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.